About VectivBio
VectivBio is global, clinical-stage biotechnology company committed to life-transforming medicines for patients living with severe, rare diseases. For Rare Disease Day 2023, we will be shining a spotlight on ‘heroes’ living with Short Bowel Syndrome and intestinal failure – a rare, organ failure condition. We are also supporting patient group community events, including an Oley Foundation mini meeting on February 28, 2022 (visit oley.org)